A pharmaceutical company that focuses on meeting the needs of the specialist physician.


Updates from The Motley Fool

Latest updates on Shire from Fool.com.  The Fool has written over 100 articles on Shire.
3 Stocks to Invest in Big Pharma

These drug kingpins are raking in the dough, which could lead to handsome returns for investors.

3 ADHD Treatment Makers to Watch

Shire, Eli Lilly, and Johnson & Johnson all produce popular treatments for this increasingly-prev...



Stock Performance

View Interactive SHPG Charts
Sponsored by

Key Data Points

Primary metrics and data points about Shire.
Current Price: $155.09
Prev Close: $155.36
Open: $156.75
Bid: $151.25
Ask: $164.39
Day's Range: $154.40 - $157.16
52wk Range: $139.36 - $205.13
Volume: 617,357
Avg Vol 1,271,517
Market Cap: $47B
P/E (ttm): 42.22
EPS (ttm): $0.00
Div & Yield: $0.31 (0.6%)

Company Rating

What our community thinks about Shire.
CAPS Rating 4 out of 5
 
156 Outperform
21 Underperform
CAPS All Stars
 
46 Outperform
8 Underperform

How do you think Shire will perform against the market?



You pick for Shire is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Flemming Ornskov, MD, CEO

34% Approve

Based on 341 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Shire.

A pharmaceutical company that focuses on meeting the needs of the specialist physician.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers